 CAMBRIDGE, Mass.--BUSINESS WIRE--Enveric Biosciences, Inc. NASDAQ: ENVB Enveric or the Company, a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Avani Kanubaddi, President COO of Enveric, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022. Mr. Kanubaddi will present on Wedn 